Patents Assigned to Sen-Jam Pharmaceutical LLC
  • Methods and compositions to inhibit symptoms associated with veisalgia
    Patent number: 11464766
    Abstract: The present invention relates to a method of reducing or preventing the symptoms associated with the intake of alcohol. The method comprises administering to a subject an effective amount of a pharmaceutical composition prior to alcohol intake. The pharmaceutical composition comprises a non-steroidal anti-inflammatory drug and a H1-antihistamine.
    Type: Grant
    Filed: September 17, 2019
    Date of Patent: October 11, 2022
    Assignee: SEN-JAM PHARMACEUTICAL LLC
    Inventors: Jacqueline M. Iversen, James M. Iversen
  • Methods and compositions to inhibit tolerance to opioids
    Patent number: 11129803
    Abstract: The present invention provides a method of inhibiting tolerance to an opioid by a human subject in need thereof. The method comprises administering an effective amount of a pharmaceutical composition to the subject during opioid therapy. The pharmaceutical composition comprises a) a non-steroidal anti-inflammatory drug (NSAID); and b) a co-agent selected from the group consisting of: fexofenadine, ketotifen, desloratadine, cetirizine, salts thereof and combinations thereof.
    Type: Grant
    Filed: September 17, 2018
    Date of Patent: September 28, 2021
    Assignee: SEN-JAM PHARMACEUTICAL LLC
    Inventors: Jacqueline Iversen, Thomas A. Dahl
  • Methods and compositions to inhibit adverse effects associated with vaccinations
    Patent number: 10874653
    Abstract: The invention relates to methods of inhibiting side effects associated with vaccination in a human subject in need thereof. The method comprises administering an effective amount of a pharmaceutical composition to the subject before the subject is vaccinated, wherein the pharmaceutical composition comprises: a) a non-steroidal anti-inflammatory drug (NSAID); and b) a co-agent selected from the group consisting of: fexofenadine, ketotifen, desloratadine and cetirizine and combinations thereof.
    Type: Grant
    Filed: August 27, 2018
    Date of Patent: December 29, 2020
    Assignee: Sen-Jam Pharmaceutical LLC
    Inventors: Jacqueline M. Iversen, Thomas A. Dahl
  • Methods and compositions to treat enteropathic arthritis
    Patent number: 10765630
    Abstract: The present invention is a method of treating enteropathic arthritis in a human subject in need thereof. The method comprises administering an effective amount of a pharmaceutical composition to the subject, wherein the pharmaceutical composition comprises: a) a non-steroidal anti-inflammatory drug (NSAID), and/or a salt thereof; and b) a co-agent selected from the group consisting of: fexofenadine, ketotifen, desloratadine, cetirizine, salts thereof and combinations thereof.
    Type: Grant
    Filed: March 15, 2019
    Date of Patent: September 8, 2020
    Assignee: SEN-JAM PHARMACEUTICAL LLC
    Inventors: Jacqueline Iversen, Thomas A. Dahl
  • Methods and compositions to inhibit dependence on opioids
    Patent number: 10675261
    Abstract: The present invention provides a method of inhibiting dependence to an opioid by a human subject in need thereof. The method comprises administering an effective amount of a pharmaceutical composition to the subject during opioid therapy. The pharmaceutical composition comprises a) a non-steroidal anti-inflammatory drug (NSAID); and b) a co-agent selected from the group consisting of: fexofenadine, ketotifen, desloratadine, cetirizine, salts thereof and combinations thereof.
    Type: Grant
    Filed: September 17, 2018
    Date of Patent: June 9, 2020
    Assignee: SEN-JAM Pharmaceutical LLC
    Inventors: Jacqueline M. Iversen, Thomas A. Dahl
  • Methods and compositions to inhibit symptoms associated with veisalgia
    Patent number: 10420756
    Abstract: The present invention relates to a method of reducing or preventing the symptoms associated with the intake of alcohol. The method comprises administering to a subject an effective amount of a pharmaceutical composition prior to alcohol intake. The pharmaceutical composition comprises a non-steroidal anti-inflammatory drug and a H1-antihistamine.
    Type: Grant
    Filed: March 18, 2016
    Date of Patent: September 24, 2019
    Assignee: SEN-JAM PHARMACEUTICAL LLC.
    Inventors: Jacqueline M. Iversen, James M. Iversen
  • Methods and Compositions to Inhibit Adverse Effects Associated with Vaccinations
    Publication number: 20190060297
    Abstract: The invention relates to methods of inhibiting side effects associated with vaccination in a human subject in need thereof. The method comprises administering an effective amount of a pharmaceutical composition to the subject before the subject is vaccinated, wherein the pharmaceutical composition comprises: a) a non-steroidal anti-inflammatory drug (NSAID); and b) a co-agent selected from the group consisting of: fexofenadine, ketotifen, desloratadine and cetirizine and combinations thereof.
    Type: Application
    Filed: August 27, 2018
    Publication date: February 28, 2019
    Applicant: Sen-Jam Pharmaceutical LLC
    Inventors: Jacqueline M. Iversen, Thomas A. Dahl